ACADIA Pharmaceuticals 2020 Proxy Statement Annual Meeting

ACADIA Pharmaceuticals' 2020 proxy statement for the June 23, 2020 annual meeting of stockholders. The document covers director elections, amendments to the employee stock purchase plan, executive compensation, and ratification of Ernst & Young LLP as independent auditor.